Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Severe Chronic Fatigue Syndrome
NCT01156922Phase 2Terminated
- Sponsor
- Haukeland University Hospital
- Start
- Jun 2010
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Haukeland University Hospital. Started Jun 2010; status: terminated.
02
Drugs
rituximab
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT01156922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156922.